Nordhealth AS (NORDH.OL)
NOK 34.8
(0.0%)
NOK 34.8
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 31.65 Million EUR | 20.5% |
| 2022 | 26.26 Million EUR | 56.94% |
| 2021 | 16.73 Million EUR | 53.1% |
| 2020 | 10.93 Million EUR | 389.83% |
| 2019 | 2.23 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 8.73 Million EUR | -0.03% |
| 2024 Q2 | 10.42 Million EUR | -50.39% |
| 2023 Q1 | 7.47 Million EUR | 4.43% |
| 2023 FY | 31.65 Million EUR | 20.5% |
| 2023 Q4 | 8.73 Million EUR | 15.53% |
| 2023 Q3 | 7.56 Million EUR | -3.94% |
| 2023 Q2 | 7.87 Million EUR | 5.3% |
| 2022 Q2 | 6.33 Million EUR | 6.22% |
| 2022 Q1 | 5.96 Million EUR | 17.17% |
| 2022 FY | 26.26 Million EUR | 56.94% |
| 2022 Q4 | 7.16 Million EUR | 5.12% |
| 2022 Q3 | 6.81 Million EUR | 7.55% |
| 2021 Q2 | 3.86 Million NOK | 0.0% |
| 2021 FY | 16.73 Million EUR | 53.1% |
| 2021 Q4 | 5.08 Million EUR | 5.01% |
| 2021 Q3 | 4.84 Million NOK | 25.32% |
| 2020 FY | 10.93 Million EUR | 0.0% |
| 2020 Q3 | 2.61 Million NOK | 0.0% |
| 2020 Q4 | 3.43 Million EUR | 31.41% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Carasent ASA | 197.76 Million NOK | 83.994% |
| CodeLab Capital AS | 50.41 Million NOK | 37.213% |